Advanced development of hemorrhagic

Ended Definitive Contract Awarded Jul 14, 2010 Last action Jul 12, 2016

Contract number: W9113M10C0056
Awardee: Sarepta Therapeutics, Inc. UEI YKM9HZ3EH6X1
Awarding agency: ACC Aberdeen Proving Ground Army Contracting Command, Department of Defense
Obligated: $106,393,196

Award facts

Opportunity: W9113M09R0008 Solicitation number

Development of Medical Countermeasure (Therapeutics) for the Treatment of Hemorrhagic Fever Viruses (HFV) Award Notice · Posted Sep 21, 2009
Contract value 41% obligated: $106,393,196.17 Current, with exercised options

$260,814,992.45 Potential, with all options
Completion date 100% complete: Jul 2, 2014 Current, with exercised options

Sep 7, 2016 Potential, with all options
Funding agency: PMPEO PBUSE Acquisition Support Center, Department of Defense
NAICS code: 541711 Research and Development in Biotechnology
PSC: 6505 Drugs And Biologicals
Set-aside: Total Small Business
Competition: Full and Open Competition after exclusion of sources · 10 offers Negotiated Proposal / Quote
Pricing: Cost Plus Incentive
Place of performance: Corvallis, OR, USA
Legislative mandates: Walsh-Healey Public Contracts Act FAR subpart 22.6

Award details come from SAM.gov/FPDS.

Transactions

Action	Obligated	Date
Terminate for Convenience P00029	-$497,059	Jul 12, 2016
Supplemental Agreement for work within scope P00028	$0	Sep 9, 2014
Funding Only Action P00027	$561,033	Aug 6, 2014
Supplemental Agreement for work within scope P00026	$0	Jun 30, 2014
Funding Only Action P00025	$1,102,523	Apr 21, 2014
Supplemental Agreement for work within scope P00024	$3,467,615	Mar 28, 2014
Funding Only Action P00023	$632,385	Feb 12, 2014
Supplemental Agreement for work within scope P00022	$0	Aug 30, 2013
Other Administrative Action P00021	$0	Jul 11, 2013
Funding Only Action P00020	$433,471	Jul 8, 2013
Funding Only Action P00019	$2,142,969	Jul 2, 2013
Funding Only Action P00018	$5,000,000	May 21, 2013
Change Order P00017	$0	May 13, 2013
Change Order P00016	$0	Dec 5, 2012
Funding Only Action P00015	-$603,633	Nov 9, 2012
Supplemental Agreement for work within scope P00014	$0	Sep 28, 2012
Supplemental Agreement for work within scope P00013	$0	Sep 4, 2012
Other Administrative Action P00012	$0	Aug 27, 2012
Change Order P00011	$0	Aug 3, 2012
Funding Only Action P00010	$5,761,090	Jul 25, 2012
Vendor Address Change P00009	$0	Jul 24, 2012
Funding Only Action P00008	$849,962	Jul 7, 2012
Funding Only Action P00007	$13,892,639	Apr 23, 2012
Funding Only Action P00006	$7,350,000	Dec 2, 2011
Funding Only Action P00005	$0	Sep 26, 2011
Funding Only Action P00004	$1,162,487	Sep 23, 2011
Funding Only Action P00003	$3,000,000	Aug 19, 2011
Change Order P00002	$18,900,000	Jun 15, 2011
Funding Only Action P00001 · Advanced development of hemorrhagic fever virus therapeutic	$16,795,984	Apr 15, 2011
Original award	$26,441,729	Jul 14, 2010

Show all 30

Quick answers

Who was awarded contract W9113M10C0056?

W9113M10C0056 was awarded to Sarepta Therapeutics, Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on July 14, 2010.

How much is contract W9113M10C0056 worth?

The government has obligated $106,393,196 on W9113M10C0056. Its potential value, with all options, is $260,814,992.

Which agency awarded contract W9113M10C0056?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W9113M10C0056, with funding from PMPEO PBUSE (Acquisition Support Center).

Was contract W9113M10C0056 competed?

The extent of competition for W9113M10C0056 was full and open competition after exclusion of sources. The government received 10 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

Every transaction and funding action
The awardee's other awards and teaming partners
Similar awards and recompete opportunities
Ask GovTribe AI about this award

Try for free Login